![logo](/logos/SERA.webp)
Sera Prognostics, Inc.
NASDAQ:SERA
7.25 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sera Prognostics, Inc. |
Symbool | SERA |
Munteenheid | USD |
Prijs | 7.25 |
Beurswaarde | 234,905,793 |
Dividendpercentage | 0% |
52-weken bereik | 1.52 - 12.355 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Evguenia Lindgardt M.B.A. |
Website | https://seraprognostics.com |
An error occurred while fetching data.
Over Sera Prognostics, Inc.
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)